These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 27873257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bacterial Two Component Systems: Overexpression and Purification: In Vitro and In Vivo Inhibitor Screens.
    Dietrich A, Gajdiss M, Türck M, Monk I, Bierbaum G.
    Methods Mol Biol; 2023; 2601():313-333. PubMed ID: 36445592
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Screening serine/threonine and tyrosine kinase inhibitors for histidine kinase inhibition.
    Wilke KE, Fihn CA, Carlson EE.
    Bioorg Med Chem; 2018 Oct 15; 26(19):5322-5326. PubMed ID: 29706527
    [Abstract] [Full Text] [Related]

  • 5. Recent advances in the Phos-tag technique focused on the analysis of phosphoproteins in a bacterial two-component system.
    Kinoshita-Kikuta E, Koike T, Kinoshita E.
    J Proteomics; 2022 Feb 10; 252():104429. PubMed ID: 34813946
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angucycline antibiotic waldiomycin recognizes common structural motif conserved in bacterial histidine kinases.
    Eguchi Y, Okajima T, Tochio N, Inukai Y, Shimizu R, Ueda S, Shinya S, Kigawa T, Fukamizo T, Igarashi M, Utsumi R.
    J Antibiot (Tokyo); 2017 Mar 10; 70(3):251-258. PubMed ID: 27999439
    [Abstract] [Full Text] [Related]

  • 11. Phos-Tag Fluorescent Gel Staining for the Quantitative Detection of His- and Asp-Phosphorylated Proteins.
    Kinoshita-Kikuta E, Kinoshita E, Koike T.
    Methods Mol Biol; 2021 Mar 10; 2261():73-78. PubMed ID: 33420985
    [Abstract] [Full Text] [Related]

  • 12. New class of competitive inhibitor of bacterial histidine kinases.
    Gilmour R, Foster JE, Sheng Q, McClain JR, Riley A, Sun PM, Ng WL, Yan D, Nicas TI, Henry K, Winkler ME.
    J Bacteriol; 2005 Dec 10; 187(23):8196-200. PubMed ID: 16291694
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Histidine kinases as targets for new antimicrobial agents.
    Matsushita M, Janda KD.
    Bioorg Med Chem; 2002 Apr 10; 10(4):855-67. PubMed ID: 11836091
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention.
    Zawadzke LE, Wu P, Cook L, Fan L, Casperson M, Kishnani M, Calambur D, Hofstead SJ, Padmanabha R.
    Anal Biochem; 2003 Mar 15; 314(2):243-52. PubMed ID: 12654311
    [Abstract] [Full Text] [Related]

  • 20. Phosphorylation of serine residues in histidine-tag sequences attached to recombinant protein kinases: a cause of heterogeneity in mass and complications in function.
    Du P, Loulakis P, Luo C, Mistry A, Simons SP, LeMotte PK, Rajamohan F, Rafidi K, Coleman KG, Geoghegan KF, Xie Z.
    Protein Expr Purif; 2005 Dec 15; 44(2):121-9. PubMed ID: 15946859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.